Topas Therapeutics
Series BTopas Therapeutics raised €18M in a Series B round in Jul 2021. The company is based in Hamburg, Germany. Investors in the round: BioMedPartners, Boehringer Ingelheim Venture Fund, EMBL Ventures and 4 others. Data as of Nov 2026.
Amount raised
€18M
€18,000,000
Native amount
18,000,000 EUR
Stage
Series B
series b
Investors
7
Provenance & confidence
Low confidenceAmount
Reported in EUR — no conversion. €18M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
7 namedBioMedPartnersBoehringer Ingelheim Venture FundEMBL VenturesEpidarex CapitalEvotecGIMVVesalius Biocapital III
Date
Jul 2021
Round type
series b
Amount (EUR)
€18M